Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05369494 · ClinicalTrials.gov registry record · NA
Infants Fed a Hydrolyzed Infant Formula
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05369494 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 33 participants.
The verdict
NCT05369494, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this non-randomized, multi-center study is to evaluate the growth, tolerance and compliance of an extensively hydrolyzed infant formula in an intended use population of infants.
Interventions
- OTHER Hydrolyzed protein infant formula with oligosaccharides
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-05-07 |
| Est. Completion | 2023-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05369494
The ClinicalTrials.gov registry entry for NCT05369494 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydrolyzed protein infant formula with oligosaccharides is the first listed.
NCT05369494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05369494 about?
NCT05369494 is a clinical study titled "Infants Fed a Hydrolyzed Infant Formula". The purpose of this non-randomized, multi-center study is to evaluate the growth, tolerance and compliance of an extensively hydrolyzed infant formula in an intended use population of infants.
What is the current status of trial NCT05369494?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-05-07. Estimated completion is 2023-11-18.
What interventions are being tested in trial NCT05369494?
The interventions under investigation include: Hydrolyzed protein infant formula with oligosaccharides (OTHER).
Who is sponsoring clinical trial NCT05369494?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.